169 related articles for article (PubMed ID: 15047740)
21. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer.
Charef-Hamza S; Trimeche M; Ziadi S; Amara K; Gaddas N; Mokni M; Sriha B; Yacoubi T; Korbi S
Cancer Lett; 2005 Jun; 224(2):185-91. PubMed ID: 15914269
[TBL] [Abstract][Full Text] [Related]
22. [Loss of heterozygosity and microsatellite instability in the region including BRCA1 of breast cancer in Chinese].
Cui J; Shen F; Jiang F; Wang Y; Bian J; Shen Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):348-50. PubMed ID: 9845764
[TBL] [Abstract][Full Text] [Related]
23. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
24. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
26. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
27. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.
Man S; Ellis IO; Sibbering M; Blamey RW; Brook JD
Cancer Res; 1996 Dec; 56(23):5484-9. PubMed ID: 8968105
[TBL] [Abstract][Full Text] [Related]
28. Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer.
Rouba A; Kaisi N; Al-Chaty E; Badin R; Pals G; Young C; Worsham MJ
Int J Mol Med; 2000 Nov; 6(5):565-9. PubMed ID: 11029525
[TBL] [Abstract][Full Text] [Related]
29. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma.
Katsama A; Sourvinos G; Zachos G; Spandidos DA
Cancer Lett; 2000 Mar; 150(2):165-70. PubMed ID: 10704738
[TBL] [Abstract][Full Text] [Related]
32. Allelic loss of chromosomal arm 8p in breast cancer progression.
Anbazhagan R; Fujii H; Gabrielson E
Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
[TBL] [Abstract][Full Text] [Related]
33. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
34. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
35. Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.
Querzoli P; Albonico G; di Iasio MG; Ferretti S; Rinaldi R; Cariello A; Pedriali M; Matteuzzi M; Maestri I; Nenci I
Breast Cancer Res Treat; 2001 Mar; 66(2):135-42. PubMed ID: 11437099
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.
Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Phillips KA; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1396-8. PubMed ID: 16835342
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.
Garcia JM; Rodriguez R; Dominguez G; Silva JM; Provencio M; Silva J; Colmenarejo A; Millan I; Muñoz C; Salas C; Coca S; España P; Bonilla F
Gut; 2003 Dec; 52(12):1756-63. PubMed ID: 14633957
[TBL] [Abstract][Full Text] [Related]
38. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.
Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA
Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271
[TBL] [Abstract][Full Text] [Related]
39. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
40. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
